Several lines of evidence suggest a relevant role for the dopamine transporter (DAT1) gene
not only as a susceptibility factor for attention-deficit hyperactivity disorder (ADHD), but also …

The dopamine transporter (DAT) is the major site of methylphenidate action, which is one of
the main drugs used to treat attention‐deficit/hyperactivity disorder (ADHD). Most …

The homozygosity of the 10‐repeat allele at dopamine transporter gene (DAT1) seems to be
associated with a poor response to methylphenidate (MPH) in children with attention …

A polymorphism in the dopamine transporter gene (DAT1) has been previously associated
with ADHD and methylphenidate has been hypothesized to block the dopamine transporter …

Several studies have implicated the dopamine transporter gene (DAT1) as conferring
susceptibility to attention deficit hyperactivity disorder (ADHD), in particular, a VNTR situated …

Stimulant medications, such as methylphenidate (MPH), are the most commonly used,
effective treatment for ADHD. MPH acts primarily by inhibiting the dopamine transporter …

This study aims to evaluate whether a previously reported association between
homozygosity for the 10-repeat allele of the dopamine transporter gene (10/10) and poor …

The dopamine transporter locus (DAT1) has been studied as a risk factor for attention-
deficit/hyperactivity disorder (ADHD) and in pharmacogenetic studies of stimulant response …

Attention deficit-hyperactivity disorder (ADHD) is a very common and heterogeneous
childhood-onset psychiatric disorder, affecting between 3% and 5% of school age children …

The dopamine transporter (DAT) plays a key role in the regulation of dopaminergic
neurotransmission and is also the major site of action for methylphenidate which is one of …